TO: All IDEAS Study Dementia Specialists and Staff
Enrollment of participants needed for Aim 1 of the study will be completed on Monday, July 31, 2017. The 90 day follow up visits and post-PET data collection for these participants will go on per protocol with final data submission anticipated in Fall, 2017.
Study enrollment to the IDEAS Study will continue on Tuesday, August 1, 2017 to enable completion of Aim 2 of the study.
Aim 2 participants will be referred for the PET scan, but there will be no 90 day follow up visit nor post-PET data collection. Aim 2 participants enrolled at Schulman IRB-approved sites will NOT require a revised informed consent document; rather, each potential participant will require a clarification letter (attached) at the time of consent. Schulman is posting the letter to the portal for access by the referring physician practices.
Sites with local IRB approval should follow local guidance. Should you have questions, please contact Alexis Dickens at IDEAS-Regulatory@acr.org
Aim 1 to Aim 2 transition information (available at https://www.ideas-study.org/referring-physicians/forms/) is also attached for your reference.
Cynthia Olson, Project Manager
The IDEAS Study Operations Team